Changes of lymphocyte subsets in elderly patients with sepsis before and after immune modulation therapy

Journal of Jilin University Medicine Edition

Volumn 41, Issue 5, 2015, Pages 994-997

  Lu, Feiping ^a   Chen, Wei ^a   Zhen, Jie ^a   Ma, Li ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Elder; Immune modulation; Lymphocyte subsets; Sepsis

Indexed keywords

THYMOSIN ALPHA1;

AGED; ARTICLE; CD3+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; ELDERLY CARE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOTHERAPY; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SEPSIS; TH1 CELL; TH2 CELL; TREATMENT DURATION;

EID: 84978230499     PISSN: 1671587X     EISSN: None     Source Type: Journal    
DOI: 10.13481/j.1671-587x.20150521     Document Type: Article

References (9)

1. Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immuno suppression: a common syndrome and new horizon for surgical intensive care [J], Trauma Acute Care Surg, 2012, 72(6): 1491-1501.
2. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock [J]. Crit Care Med, 2008, 36(1):296-327.
3. Wa D, Meydani SN. Age-associated change in immune and inflammatory responses: impact of vitamin E intervention [J]. J Leukoc Biol, 2008, 84(4): 900-914.
4. Hotchkiss RS, Opal S. Immunotherapy for sepsis: a new approach against an ancient foe [J]. N Engl J Med, 2010, 363(1): 87-89.
5. Osuchowski MF, Welch K, Siddiqui J, et al. Circulationg cytokine /inhibitor profiles reshape the understanding of the sirs/cars continuum in sepsis and predict mortality [J]. J Immunol, 2006, 177(3): 1967-1974.
6. Huang LF, Yao Yin, Dong N, et al. Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study [J]. Crit Care, 2010, 14(1): 1-10.
7. + Treg and immune control [J]. J Clin Invest, 2004, 114(9): 1209-1217.
8. Kumpf O, Schumann RR. Genetic variation in innate immunity pathways and their potential contribution to the SIRS/CARS debate: Evidence from human studies and animal models [J]. J Innate Immun, 2010, 2(5): 381-394.
9. Hotchkiss RS, Karl LE. The pathophysiology and treatment of sepsis [J]. N Engl J Med, 2003, 348(2): 138-150.